Scientific or Scholarly Rationale or Purpose
Researcher Help: Describe the Scientific or Scholarly Rationale or Purpose
| General considerations | The design, conduct and monitoring of a research activity involving human subjects is the responsibility of the Principal Investigator (PI) who provides a complete written description of the proposed research (a “research protocol”) to a DOH Institutional Review Board (IRB), even if portions of the activity are carried out by others or contracted out.
Biomedical ResearchDescribe the background, including previous human subject or animal research and references that are relevant to the design and conduct of the study. Where new techniques or procedures are to be used, a description of preliminary or early work should be provided. If an FDA Investigational New Drug (IND) is to be used, animal data on the drug should be included (summarize, and indicate where detailed information may be found in the protocol). Social Science ResearchDescribe the background, including previous research (for example, research in similar populations, or previous research that is being extended by this project). If pilot studies or small-scale research have been conducted previously, describe this, and how the current project builds upon that work.
Registry Research and Data AnalysisResearchers who are requesting use of non-public data from the Office of Vital Statistics, or the Florida Cancer Registry Data System, or the Florida Birth Defects Registry, or other data repositories at the Department of Health are engaged in registry research or data analysis. The regulatory criteria for IRB approval are the same for this kind of research as for other kinds of research, so researchers need to provide similar kinds of information to the IRB so it can assess the research.
|
| Required Determinations by the IRB | In order to approve research, the IRB has to make determinations required by regulation. Description of the scientific and scholarly rationale is required because the IRB is required in regulation to determine that "Risks to subjects are minimized: (i) By using procedures which are consistent with sound research design and which do not unnecessarily expose subjects to risk, and (ii) whenever appropriate, by using procedures already being performed on the subjects for diagnostic or treatment purposes." (45 CFR 46.111(a)(1)) |
| Accreditation Element |
|
| Regulations | 45 CFR 46.111; 21 CFR 56.111 |
| Guidance | |
| References |
|
